News Releases

News Releases

Microbix Completes Brokered Private Placement – Gross Proceeds of $2.3 Million
OCTOBER 19, 2017

Microbix Completes Brokered Private Placement – Gross Proceeds of $2.3 Million

OCTOBER 19, 2017 Angus Gastle

TORONTO, October 19, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological produ...

Read more
Microbix Announces End of Legal Dispute – Allegations by ZeptoMetrix Withdrawn
OCTOBER 11, 2017

Microbix Announces End of Legal Dispute – Allegations by ZeptoMetrix Withdrawn

OCTOBER 11, 2017 Angus Gastle

TORONTO, October 11, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announ...

Read more
Microbix Announces First Shipment of Bioreactor Antigen
SEPTEMBER 13, 2017

Microbix Announces First Shipment of Bioreactor Antigen

SEPTEMBER 13, 2017 Angus Gastle

Customer Validation of New Manufacturing Process Completed TORONTO: September 13, 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer ...

Read more
Microbix to Amend Share Purchase Warrant Terms
AUGUST 24, 2017

Microbix to Amend Share Purchase Warrant Terms

AUGUST 24, 2017 Angus Gastle

TORONTO August 24 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces i...

Read more
Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%
AUGUST 14, 2017

Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%

AUGUST 14, 2017 Angus Gastle

TORONTO, August 14, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financi...

Read more

 

img

Added to cart successfully!